Teachers Retirement System of The State of Kentucky lowered its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) by 23.3% during the second quarter, according to its most recent filing with the SEC. The firm owned 2,300 shares of the specialty pharmaceutical company’s stock after selling 700 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in ANI Pharmaceuticals were worth $108,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. BNP Paribas Arbitrage SA lifted its position in shares of ANI Pharmaceuticals by 44.6% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,152 shares of the specialty pharmaceutical company’s stock worth $101,000 after purchasing an additional 664 shares during the period. Envestnet Asset Management Inc. lifted its position in shares of ANI Pharmaceuticals by 82.3% in the 1st quarter. Envestnet Asset Management Inc. now owns 3,493 shares of the specialty pharmaceutical company’s stock worth $172,000 after purchasing an additional 1,577 shares during the period. Municipal Employees Retirement System of Michigan lifted its position in shares of ANI Pharmaceuticals by 132.0% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,200 shares of the specialty pharmaceutical company’s stock worth $197,000 after purchasing an additional 2,390 shares during the period. Oppenheimer Asset Management Inc. acquired a new position in shares of ANI Pharmaceuticals in the 1st quarter worth approximately $204,000. Finally, Stevens Capital Management LP acquired a new position in shares of ANI Pharmaceuticals in the 2nd quarter worth approximately $207,000. Hedge funds and other institutional investors own 55.96% of the company’s stock.

Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) opened at 58.56 on Tuesday. The company has a market cap of $681.52 million, a price-to-earnings ratio of 128.14 and a beta of 3.05. The stock has a 50 day moving average of $54.15 and a 200 day moving average of $49.14. ANI Pharmaceuticals, Inc. has a 1-year low of $42.23 and a 1-year high of $65.81.

ANI Pharmaceuticals (NASDAQ:ANIP) last announced its quarterly earnings results on Thursday, August 3rd. The specialty pharmaceutical company reported $0.98 EPS for the quarter, topping analysts’ consensus estimates of $0.79 by $0.19. ANI Pharmaceuticals had a return on equity of 22.70% and a net margin of 3.35%. The company had revenue of $44.80 million during the quarter, compared to analyst estimates of $43.20 million. During the same quarter last year, the firm posted $1.11 earnings per share. The firm’s revenue was up 43.0% on a year-over-year basis. Analysts predict that ANI Pharmaceuticals, Inc. will post $3.84 EPS for the current year.

ANIP has been the topic of a number of recent analyst reports. Canaccord Genuity initiated coverage on shares of ANI Pharmaceuticals in a research report on Monday, July 31st. They issued a “buy” rating and a $60.00 price target on the stock. Guggenheim restated a “buy” rating and issued a $80.00 price target on shares of ANI Pharmaceuticals in a research report on Tuesday, July 4th. Zacks Investment Research upgraded shares of ANI Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Wednesday, July 5th. Finally, BidaskClub upgraded shares of ANI Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Friday, August 18th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. ANI Pharmaceuticals presently has an average rating of “Hold” and an average price target of $67.33.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://theolympiareport.com/2017/10/31/ani-pharmaceuticals-inc-anip-stake-lessened-by-teachers-retirement-system-of-the-state-of-kentucky.html.

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations.

Institutional Ownership by Quarter for ANI Pharmaceuticals (NASDAQ:ANIP)

Receive News & Ratings for ANI Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANI Pharmaceuticals Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.